Sanitary registration approved for Cuban product for Alzheimer’s disease
The Molecular Immunology Center (CIM) announced today that the regulatory authority for medicines, equipment and medical devices in Cuba approved the Health Register conditional of Cuban product NeuroEpofor patients with mild and